deferiprone has been researched along with Acute Disease in 3 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral deferiprone holds promise in the treatment of iron poisoning in humans." | 5.31 | The efficacy of oral deferiprone in acute iron poisoning. ( Bentur, Y; Berkovitch, M; Klein, J; Koren, G; Livne, A; Lushkov, G; Segal, M; Talmor, C, 2000) |
| "Deferiprone is the most widely studied oral iron chelator and, at present, the only one shown to be effective in achieving negative iron balance in long-term clinical trials for chronic iron overload." | 4.79 | Oral iron chelation with deferiprone. ( Diav-Citrin, O; Koren, G, 1997) |
| "Oral deferiprone holds promise in the treatment of iron poisoning in humans." | 1.31 | The efficacy of oral deferiprone in acute iron poisoning. ( Bentur, Y; Berkovitch, M; Klein, J; Koren, G; Livne, A; Lushkov, G; Segal, M; Talmor, C, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Viprakasit, V | 1 |
| Nuchprayoon, I | 1 |
| Chuansumrit, A | 1 |
| Torcharus, K | 1 |
| Pongtanakul, B | 1 |
| Laothamatas, J | 1 |
| Srichairatanakool, S | 1 |
| Pooliam, J | 1 |
| Supajitkasem, S | 1 |
| Suriyaphol, P | 1 |
| Tanphaichitr, VS | 1 |
| Tuchinda, S | 1 |
| Diav-Citrin, O | 1 |
| Koren, G | 2 |
| Berkovitch, M | 1 |
| Livne, A | 1 |
| Lushkov, G | 1 |
| Segal, M | 1 |
| Talmor, C | 1 |
| Bentur, Y | 1 |
| Klein, J | 1 |
1 review available for deferiprone and Acute Disease
| Article | Year |
|---|---|
Oral iron chelation with deferiprone.
Topics: Acute Disease; Administration, Oral; Anemia; Chelation Therapy; Child; Deferiprone; Humans; Iron Ove | 1997 |
1 trial available for deferiprone and Acute Disease
| Article | Year |
|---|---|
Deferiprone (GPO-L-ONE(®) ) monotherapy reduces iron overload in transfusion-dependent thalassemias: 1-year results from a multicenter prospective, single arm, open label, dose escalating phase III pediatric study (GPO-L-ONE; A001) from Thailand.
Topics: Acute Disease; Administration, Oral; Adolescent; beta-Thalassemia; Child; Child, Preschool; Deferipr | 2013 |
1 other study available for deferiprone and Acute Disease
| Article | Year |
|---|---|
The efficacy of oral deferiprone in acute iron poisoning.
Topics: Acute Disease; Administration, Oral; Animals; Biological Availability; Deferiprone; Disease Models, | 2000 |